Community Health Systems’ (CYH) Underweight Rating Reaffirmed at Barclays

Community Health Systems (NYSE:CYH)‘s stock had its “underweight” rating restated by stock analysts at Barclays in a note issued to investors on Wednesday, MarketBeat reports. They currently have a $3.00 price objective on the stock. Barclays‘s price target suggests a potential downside of 21.22% from the company’s previous close.

A number of other equities analysts have also commented on the stock. Zacks Research lowered shares of Community Health Systems from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 24th. Weiss Ratings upgraded shares of Community Health Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, July 2nd. Truist Financial dropped their price target on shares of Community Health Systems from $3.50 to $3.00 and set a “hold” rating for the company in a research report on Thursday, April 23rd. Finally, Wall Street Zen cut Community Health Systems from a “hold” rating to a “sell” rating in a research note on Saturday, April 25th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Community Health Systems presently has a consensus rating of “Reduce” and a consensus price target of $3.28.

Community Health Systems Trading Up 3.5%

NYSE:CYH opened at $3.81 on Wednesday. The stock has a 50 day simple moving average of $3.01 and a 200 day simple moving average of $3.13. The stock has a market cap of $536.62 million, a P/E ratio of 1.11 and a beta of 1.81. Community Health Systems has a 1-year low of $2.38 and a 1-year high of $4.43.

Community Health Systems (NYSE:CYH) last issued its quarterly earnings data on Tuesday, April 21st. The company reported ($0.48) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.30). Community Health Systems had a net margin of 3.78% and a negative return on equity of 7.62%. The firm had revenue of $2.96 billion during the quarter, compared to analyst estimates of $2.89 billion. During the same period in the prior year, the company earned ($0.03) earnings per share. The business’s quarterly revenue was down 6.1% compared to the same quarter last year. Community Health Systems has set its FY 2026 guidance at -0.600-0.000 EPS. As a group, sell-side analysts forecast that Community Health Systems will post -0.58 EPS for the current year.

Institutional Investors Weigh In On Community Health Systems

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada increased its position in Community Health Systems by 601.9% during the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock worth $29,000 after purchasing an additional 7,963 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in Community Health Systems in the fourth quarter valued at approximately $34,000. Wealthcare Advisory Partners LLC bought a new stake in shares of Community Health Systems during the fourth quarter worth $35,000. Valeo Financial Advisors LLC acquired a new position in shares of Community Health Systems during the fourth quarter worth $39,000. Finally, Quarry LP bought a new position in shares of Community Health Systems in the 3rd quarter valued at $39,000. 84.99% of the stock is owned by institutional investors.

Community Health Systems Company Profile

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.